Advances in pharmacotherapy for allergic conjunctivitis.

Item

http://www.wikidata.org/entity/Q38460976

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Advances in pharmacotherapy for allergic conjunctivitis.

@en

type

Item

label

Advances in pharmacotherapy for allergic conjunctivitis.

@en

prefLabel

Advances in pharmacotherapy for allergic conjunctivitis.

@en

P1476

Advances in pharmacotherapy for allergic conjunctivitis.

@en

P2093

Lisa M Smith

http://www.w3.org/2001/XMLSchema#string

Mark B Abelson

http://www.w3.org/2001/XMLSchema#string

Michael Korchak

http://www.w3.org/2001/XMLSchema#string

Salim I Butrus

http://www.w3.org/2001/XMLSchema#string

Sirikishan Shetty

http://www.w3.org/2001/XMLSchema#string

P2860

Fluticasone reverses oxymetazoline-induced tachyphylaxis of response and rebound congestion.

Pemirolast potassium 0.1% ophthalmic solution is an effective treatment for allergic conjunctivitis: a pooled analysis of two prospective, randomized, double-masked, placebo-controlled, phase III studies.

Topical interleukin 1 receptor antagonist for treatment of dry eye disease: a randomized clinical trial.

Ocular itch relief with alcaftadine 0.25% versus olopatadine 0.2% in allergic conjunctivitis: pooled analysis of two multicenter randomized clinical trials.

Topical azelastine in perennial allergic conjunctivitis.

Comparative study of 0.1% olopatadine hydrochloride and 0.5% ketorolac tromethamine in the treatment of seasonal allergic conjunctivitis.

Comparison of ketotifen fumarate ophthalmic solution alone, desloratadine alone, and their combination for inhibition of the signs and symptoms of seasonal allergic rhinoconjunctivitis in the conjunctival allergen challenge model: a double-masked, p

Randomized, double-masked comparison of olopatadine ophthalmic solution, mometasone furoate monohydrate nasal spray, and fexofenadine hydrochloride tablets using the conjunctival and nasal allergen challenge models.

Efficacy and safety of sublingual immunotherapy with grass allergen tablets for seasonal allergic rhinoconjunctivitis.

The epidemiology of ocular and nasal allergy in the United States, 1988-1994.

P304

1219-1231

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14656566.2015.1040760

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-05-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25943976

http://www.w3.org/2001/XMLSchema#string

P921

pharmacotherapy